118 related articles for article (PubMed ID: 37307530)
21. Impact of gender and primary tumor location on outcome of patients with cutaneous melanoma.
Voinea S; Blidaru A; Panaitescu E; Sandru A
J Med Life; 2016; 9(4):444-448. PubMed ID: 27928453
[No Abstract] [Full Text] [Related]
22. Intraocular tumor-associated lymphangiogenesis a novel prognostic factor for ciliary body melanomas with extraocular extension?
Heindl LM; Hofmann TN; Adler W; Knorr HL; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Ophthalmology; 2010 Feb; 117(2):334-42. PubMed ID: 19892405
[TBL] [Abstract][Full Text] [Related]
23. Vascular endothelial growth factor C mRNA expression correlates with stage of progression in patients with melanoma.
Goydos JS; Gorski DH
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5962-7. PubMed ID: 14676121
[TBL] [Abstract][Full Text] [Related]
24. Expression of Molecular Markers of Angiogenesis, Lymphangiogenesis, and Proliferation Depending on the Stage of Skin Melanoma.
Bgatova NP; Lomakin AI; Fursov SA; Kachesov IV; Chepko SA; Isakova NB; Borodin YI; Voytsitsky VE; Konenkov VI
Bull Exp Biol Med; 2016 Aug; 161(4):542-6. PubMed ID: 27590758
[TBL] [Abstract][Full Text] [Related]
25. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of cyclooxygenase-2 in metastatic melanoma affects progression free survival.
Panza E; De Cicco P; Ercolano G; Armogida C; Scognamiglio G; Anniciello AM; Botti G; Cirino G; Ianaro A
Oncotarget; 2016 Aug; 7(35):57077-57085. PubMed ID: 27494851
[TBL] [Abstract][Full Text] [Related]
27. Melanoma gene expression and clinical course.
Vourc'h-Jourdain M; Volteau C; Nguyen JM; Khammari A; Dreno B
Arch Dermatol Res; 2009 Oct; 301(9):673-9. PubMed ID: 19326132
[TBL] [Abstract][Full Text] [Related]
28. Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma.
Straume O; Jackson DG; Akslen LA
Clin Cancer Res; 2003 Jan; 9(1):250-6. PubMed ID: 12538477
[TBL] [Abstract][Full Text] [Related]
29. Lymphangiogenesis and Anti-lymphangiogenesis in Cutaneous Melanoma.
Raica M; Jitariu AA; Cimpean AM
Anticancer Res; 2016 Sep; 36(9):4427-35. PubMed ID: 27630278
[TBL] [Abstract][Full Text] [Related]
30. Matrix metalloproteinase-12 expression is increased in cutaneous melanoma and associated with tumor aggressiveness.
Zhang Z; Zhu S; Yang Y; Ma X; Guo S
Tumour Biol; 2015 Nov; 36(11):8593-600. PubMed ID: 26040769
[TBL] [Abstract][Full Text] [Related]
31. Neuroblastoma progression correlates with downregulation of the lymphangiogenesis inhibitor sVEGFR-2.
Becker J; Pavlakovic H; Ludewig F; Wilting F; Weich HA; Albuquerque R; Ambati J; Wilting J
Clin Cancer Res; 2010 Mar; 16(5):1431-41. PubMed ID: 20179233
[TBL] [Abstract][Full Text] [Related]
32. High G2 and S-phase expressed 1 expression promotes acral melanoma progression and correlates with poor clinical prognosis.
Xu T; Ma M; Chi Z; Si L; Sheng X; Cui C; Dai J; Yu S; Yan J; Yu H; Wu X; Tang H; Yu J; Kong Y; Guo J
Cancer Sci; 2018 Jun; 109(6):1787-1798. PubMed ID: 29660787
[TBL] [Abstract][Full Text] [Related]
33. Impact of clinical and histopathological characteristics on the disease-free survival of stage I-II acral melanoma patients.
Borges de Barros Primo R; Brito Nobre A; Santos BN; Nunes LF; Fernandes R; Abrão Possik P; Santos Bernardes S
Int J Dermatol; 2023 Oct; 62(10):1281-1288. PubMed ID: 37596798
[TBL] [Abstract][Full Text] [Related]
34. BRAF mutational status as a prognostic marker for survival in malignant melanoma: a systematic review and meta-analysis.
Ny L; Hernberg M; Nyakas M; Koivunen J; Oddershede L; Yoon M; Wang X; Guyot P; Geisler J
Acta Oncol; 2020 Jul; 59(7):833-844. PubMed ID: 32285732
[No Abstract] [Full Text] [Related]
35. Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: an analysis of 215 cases from the Malmö Diet and Cancer Study.
Jonsson L; Bergman J; Nodin B; Manjer J; Pontén F; Uhlén M; Jirström K
J Transl Med; 2011 Jul; 9():114. PubMed ID: 21777469
[TBL] [Abstract][Full Text] [Related]
36. FOXD2-AS1 correlates with the malignant status and regulates cell proliferation, migration, and invasion in cutaneous melanoma.
Ren W; Zhu Z; Wu L
J Cell Biochem; 2019 Apr; 120(4):5417-5423. PubMed ID: 30426532
[TBL] [Abstract][Full Text] [Related]
37. Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma.
Kyrgidis A; Tzellos T; Mocellin S; Apalla Z; Lallas A; Pilati P; Stratigos A
Cochrane Database Syst Rev; 2015 May; 2015(5):CD010307. PubMed ID: 25978975
[TBL] [Abstract][Full Text] [Related]
38. Aspartate beta-hydroxylase domain containing 1 as a prognostic marker associated with immune infiltration in skin cutaneous melanoma.
Sun S; Deng M; Wen J; Chen X; Xu J; Liu Y; Wan H; Wang J; Yan L; He Y; Xu Y
BMC Cancer; 2023 Mar; 23(1):292. PubMed ID: 37004045
[TBL] [Abstract][Full Text] [Related]
39. Epidermal growth factor receptor pathway polymorphisms and the prognosis of hepatocellular carcinoma.
Wang W; Ma XP; Shi Z; Zhang P; Ding DL; Huang HX; Saiyin HG; Chen TY; Lu PX; Wang NJ; Yu H; Sun J; Zheng SL; Yu L; Xu J; Jiang DK
Am J Cancer Res; 2015; 5(1):396-410. PubMed ID: 25628948
[TBL] [Abstract][Full Text] [Related]
40. Significance of Vascular Endothelial Growth Factor (VEGF)-C and VEGF-D in the Progression of Cutaneous Melanoma.
Špirić Z; Eri Ž; Erić M
Int J Surg Pathol; 2015 Dec; 23(8):629-37. PubMed ID: 25911567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]